Top Institutions in Psychiatry and Psychedelic Research
Leading institutions conduct randomized controlled trials, often phase 2 and 3, integrating psychotherapy with psychedelic administration, while addressing challenges such as blinding and expectancy effects. They combine clinical expertise in psychiatry, neuropharmacology, and psychotherapy with rigorous trial design and safety monitoring.
-
#1
Johns Hopkins University
Baltimore, MD
Pioneers in psychedelic research with extensive clinical trials on psilocybin for depression and other psychiatric disorders, combining rigorous methodology with integrated psychotherapy approaches.
Key Differentiators
- Psychiatry
- Neuropharmacology
- Psychedelic Research
-
#2
Imperial College London
London, N/A
Leads innovative neuroimaging and clinical trials investigating psilocybin-assisted therapy for depression, contributing critical insights into brain mechanisms and therapeutic effects.
Key Differentiators
- Psychiatry
- Neuroscience
- Psychedelic Medicine
-
#3
New York University (NYU) Langone Health
New York, NY
Active in clinical research on psychedelics for mood disorders, integrating psychotherapy and pharmacology with a focus on treatment-resistant populations.
Key Differentiators
- Psychiatry
- Clinical Trials
- Psychedelic Research
-
#4
University of California, San Francisco (UCSF)
San Francisco, CA
Known for clinical and translational research in psychiatry and addiction, with emerging programs in psychedelic-assisted therapies for depression and substance use disorders.
Key Differentiators
- Psychiatry
- Addiction Medicine
- Psychedelic Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.
